Legal Representation
Attorney
William L. Warren
USPTO Deadlines
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 24, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Aug 24, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Feb 11, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Feb 11, 2020 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 11, 2020 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jan 21, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 21, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 21, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 27, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 27, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 27, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 23, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 17, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 6, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical compositions for parenteral delivery containing leukocytes for treating inflammatory, immune, and auto-immune diseases and disorders, including leukemic cancers and graft versus host disease (GVHD)
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
CORD TREG
Classification
International Classes
005